Browsing by Author Parkinson, Bonny

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 6 of 6
Issue DateTitleAuthor(s)Citation
2015Disinvestment and Value-Based Purchasing Strategies for Pharmaceuticals: An International ReviewElshaug, Adam; Pearson, Sallie-Anne; Choudhury, Moni; Clement, Fiona; Crausaz, Steffan; Garner, Sarah; Godman, Brian; Lopert, Ruth; Parkinson, Bonny; Sermet, Catherine; Viney, Rosalie C.; School of Public Health: Public Health; PharmacyDisinvestment and Value-Based Purchasing Strategies for Pharmaceuticals: An International Review, PharmacoEconomics, vol.33, 9, 2015,pp 905-924
2014Economic evaluations of trastuzumab in HER2-positive metastatic breast cancer: a systematic review and critiquePearson, Sallie-Anne; Parkinson, Bonny; Viney, Rosalie; PharmacyEconomic evaluations of trastuzumab in HER2-positive metastatic breast cancer: a systematic review and critique, The European Journal of Health Economics, vol.15, 1, 2014,pp 93-112
2006Listen Hear! Economic impact and cost of hearing loss in Australia.Hogan, Anthony; Parkinson, Bonny; Puzzello, L; Communication DisordersListen Hear! Economic impact and cost of hearing loss in Australia., Access Economics, vol.2006,(February),2006,pp N/A-N/A
2017Long-term health care costs for patients with prostate cancer: a population-wide longitudinal study in New South Wales, AustraliaSmith, David; Bang, A; Cronin, P; Haywood, Philip; Kirkbride, B; Parkinson, Bonny; School of Public Health: Public HealthLong-term health care costs for patients with prostate cancer: a population-wide longitudinal study in New South Wales, Australia, Asia-Pacific Journal of Clinical Oncology, vol.13, 3, 2017,pp 160-171
2016Real-World Evidence: A Comparison of the Australian Herceptin Program and Clinical Trials of Trastuzumab for HER2-Positive Metastatic Breast CancerPearson, Sallie-Anne; Goodall, Stephen; Haas, Marion; Parkinson, Bonny; Srasuebkul, Preeyaporn; Viney, Rosalie C.; PharmacyReal-World Evidence: A Comparison of the Australian Herceptin Program and Clinical Trials of Trastuzumab for HER2-Positive Metastatic Breast Cancer, PharmacoEconomics, vol.34, 10, 2016,pp 1039-1050
2016Real-World Evidence: A Comparison of the Australian Herceptin Program and Clinical Trials of Trastuzumab for HER2-Positive Metastatic Breast CancerPearson, Sallie-Anne; Goodall, Stephen; Haas, Marion; Parkinson, Bonny; Srasuebkul, Preeyaporn; Viney, Rosalie C.; PharmacyReal-World Evidence: A Comparison of the Australian Herceptin Program and Clinical Trials of Trastuzumab for HER2-Positive Metastatic Breast Cancer, PharmacoEconomics, vol.34, 10, 2016,pp 1039-1050